1Oesterling JE, Jacobsen SJ, Klee GG, et al. Free complexed and total serum prostate specific antigen:the establishment of appropriate reference ranges for their concentrations and ratios[J]. J Urol, 1995,154:1090-1095.
2Christensson A, Bjork T, Nilsson O, et al. Serum prostate specific antigen eomplexed to a 1-antiehymotrypsin as an indicator of prostate cancer[J]. J Urol, 1993,150 : 100-105.
3Catalona WJ, mith DS, Wolfert RL, et al. Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening[J]. J AMA, 1995,274:1214-1220.
4Shin E, Shigehiro S, Makoto O, et al. The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan[J]. Cancer, 1997,79:90-98.
5Benson MC, Whang IS, Olsson CA, et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen[J]. J Urol, 1992,147:817-821.
6Woodrum DL, Brawer MK, Partin AW, etal. Interpretation of free prostate specific antigen clinical research studies for detection of prostate cancer [J]. J Urol, 1998,159:5.
